Jim Cramer’s Mad Dash: Janet Yellen Was Wrong about Biotechs

– On CNBC’s Mad Dash, Cramer discussed the powerful performance of biotech stock Intercept (ICPT) which saw a 16.59% increase on Tuesday after strong data for its liver disease treatment. Cramer More...

Jim Cramer Says Nelson Peltz Should ‘Go After Losers like Coca-Cola’

– On CNBC’s Squawk Box, Jim Cramer said the UBS upgrade of PepsiCo (PEP) was worth watching, and added that CEO Indra Nooyi has created tremendous value for the company, whose stock is up More...